Sybil Shainwald

Last updated
Sybil Shainwald
BornApril 27, 1928
New York City, NY
NationalityAmerican
EducationCollege of William and Mary BA 1948
Columbia University MA 1972
New York Law School JD 1976
Occupation(s) Attorney, women's health rights activist, writer, lecturer
Known forFormer chair of the National Women's Health Network, co-founder of Health Action International and Trial Lawyers for Public Justice

Sybil Shainwald (born April 27, 1928) is an American attorney specializing in women's health law and an activist for women's health reform. She has represented thousands of women and their children in individual and class action suits against manufacturers of harmful drugs, devices, and procedures. Shainwald is former chair of the National Women's Health Network, co-founder of Health Action International and Trial Lawyers for Public Justice.

Contents

Personal life and education

Shainwald was born in New York City to Morris and Anne Brodkin, children of Russian Jewish immigrants. She graduated from James Madison High School in Brooklyn [1] and at 16 entered William and Mary College in Williamsburg, Virginia. She graduated first in her class with a BA in history in 1948 and then taught in New York City and New Rochelle, New York, schools while raising four children. In 1960 she married CPA and consumer advocate Sidney Shainwald. She then attended graduate school at Columbia University where she received her M.A. in history in 1972, focusing on the consumer movement. In 1972 she was awarded a National Endowment for the Humanities grant to establish the Center for the Study of the Consumer Movement at Consumers Union, which she directed from 1972 to 1978. Concurrently, she attended New York Law School's evening division, where she earned her J.D. degree in 1976.

Law career

Shainwald first became a trial assistant in the law office of Alfred S. Julien in New York City. [1] In the late 1970s, as co-counsel, she successfully represented Joyce Bichler in Bichler v. Lilly. Bichler, who at 17 had developed clear cell adenocarcinoma of the cervix and vagina requiring the removal of her reproductive organs, had brought a product liability action against the Eli Lilly pharmaceutical company for damages sustained through her mother's use of DES (diethylstilbestrol) while she was pregnant with her. This was the first case that held drug manufacturers liable for the health problems of children whose mothers had taken the synthetic estrogen drug DES to prevent miscarriage. [2] [3] The case was appealed by Lilly in 1979. Bichler turned down Lilly's settlement offer of $100,000 when Shainwald told her "that if money was not essential, and if she could hold out for a jury verdict, it would be a victory for women everywhere." [4] Bichler won the appeal in 1982 and was awarded $500,000 by the jury. [4]

Women's health reform became Shainwald's cause. Beginning in the late 1980s, Shainwald represented women whose silicone gel breast implants had leaked and caused a variety of autoimmune, neurological, and rheumatological problems. [3] As a member of the Settlement Committee in the consolidated cases known as MDL 926, she was successful in setting up a $25 million fund for women outside the U.S. who were injured by faulty breast implants. Shainwald litigated cases involving various forms of birth control including the Dalkon Shield (an intrauterine device), representing 2,000 women in a class action against A.H. Robins Company, and was successful in getting equity for foreign women. She also litigated against birth control pills, the prenatal diagnostic test known as chorionic villus sampling, the lactation inhibitor Parlodel, the anti-obesity drug Fen-Phen, and other products detrimental to women's health. [3]

In 1995, she represented women in state and federal class action suits against Wyeth-Ayerst Laboratories, the maker of Norplant, a hormone capsule implant designed as a long-acting contraceptive and used by about a million women. [5] Shainwald claimed that it wasn't tested appropriately. In 1989 she had urged the FDA not to approve its sale when she testified before the agency on behalf of Health Action International, a consortium of health concerns. She warned of the device's serious problems, among them its removal, infection at the implant site, and unknown long-term side effects. [5]

In 1996, Shainwald won a class action lawsuit that established a court-supervised program funded by the pharmaceutical companies that manufactured DES. The result was the establishment of an Emergency Fund for DES daughters that included compensation for, among other expenses, medical costs not reimbursed by insurance companies, psychological counseling, and costs relating to infertility due to DES exposure. The fund also provided for a DES education and outreach campaign aimed at the general public. [3] [4]

Shainwald was also instrumental in changing the statute of limitations for latent injuries in New York State to a discovery statute in 1986, and filed the first case under the Revival and Discovery Statute, which allowed dismissed cases to be filed again for a period of one year. [6]

Health advocacy

Shainwald was chair of the National Women's Health Network in the 1980s, co-founder of Health Action International, a founding member of Trial Lawyers for Public Justice and a member of the FDA's Consumer Consortium. She has also been involved with the Hysterectomy Educational Resources and Services (HERS) Foundation. [7]

In addition to advocacy in the courtroom, Shainwald has written, testified, and lectured about obstetrical malpractice, unnecessary hysterectomies, and product liability litigation. [8] In the 1980s she traveled internationally to educate women on the toxicity of Depo Provera, a drug manufactured by Upjohn Corporation. Though not approved by the FDA for contraceptive use, these birth control shots, given every three months, were marketed in 80 foreign countries and, through legal loopholes, to poor, minority, and mentally incapacitated women in the U.S. as well. [9] Shainwald estimated that 20,000 American women were prescribed this drug, linked to cancer in lab animals, as a contraceptive and to treat PMS and endometriosis, and were not told about its side effects. She called its distribution "human experimentation on a massive scale." Shainwald's writings and testimony before the FDA and Congress have had a significant impact in raising awareness on crucial women's health issues.

Shainwald has received numerous awards for her advocacy, including the President's Medal from New York Law School in 2007, the Dean's Award from Columbia University (2009), the Susan B. Anthony Award from the National Organization for Women, Doctor of Laws – Honorary Degree from New York Law School in 2000, and the New York County Lawyers Association's 2010 Edith I. Spivak Award.

Lecture series

In tribute to her late husband, Shainwald established the Sidney Shainwald Public Interest Lectures at New York Law School in 2004 to carry on their legacy of professionalism, ethics, and social responsibility. [6] Speakers have included Senator Edward M. Kennedy, Laurence Tribe, U.S. Supreme Court Justices Sandra Day O'Connor, Ruth Bader Ginsburg and Stephen G. Breyer, former U.S. Senator and Secretary of Defense Chuck Hagel, Secretary of State John Kerry, former Speaker of the House Nancy Pelosi, and former Senate Majority Leader George J. Mitchell.

Related Research Articles

<span class="mw-page-title-main">Emergency contraception</span> Birth control measures taken after sexual intercourse

Emergency contraception (EC) is a birth control measure, used after sexual intercourse to prevent pregnancy.

<span class="mw-page-title-main">Levonorgestrel</span> Hormonal medication used for birth control

Levonorgestrel is a hormonal medication which is used in a number of birth control methods. It is combined with an estrogen to make combination birth control pills. As an emergency birth control, sold under the brand names Plan B One-Step and Julie, among others, it is useful within 72 hours of unprotected sex. The more time that has passed since sex, the less effective the medication becomes, and it does not work after pregnancy (implantation) has occurred. Levonorgestrel works by preventing ovulation or fertilization from occurring. It decreases the chances of pregnancy by 57–93%. In an intrauterine device (IUD), such as Mirena among others, it is effective for the long-term prevention of pregnancy. A levonorgestrel-releasing implant is also available in some countries.

Levonorgestrel-releasing implant, sold under the brand name Jadelle among others, are devices that release levonorgestrel for birth control. It is one of the most effective forms of birth control with a one-year failure rate around 0.05%. The device is placed under the skin and lasts for up to five years. It may be used by women who have a history of pelvic inflammatory disease and therefore cannot use an intrauterine device. Following removal, fertility quickly returns.

<span class="mw-page-title-main">Contraceptive patch</span> Transdermal patch applied to prevent pregnancy

A contraceptive patch, also known as "the patch", is a transdermal patch applied to the skin that releases synthetic oestrogen and progestogen hormones to prevent pregnancy. They have been shown to be as effective as the combined oral contraceptive pill with perfect use, and the patch may be more effective in typical use.

<span class="mw-page-title-main">Frances Oldham Kelsey</span> Canadian-American physician and pharmacologist (1914–2015)

Frances Kathleen Oldham Kelsey was a Canadian-American pharmacologist and physician. As a reviewer for the U.S. Food and Drug Administration (FDA), she refused to authorize thalidomide for market because she had concerns about the lack of evidence regarding the drug's safety. Her concerns proved to be justified when it was shown that thalidomide caused serious birth defects. Kelsey's career intersected with the passage of laws strengthening FDA oversight of pharmaceuticals. Kelsey was the second woman to receive the President's Award for Distinguished Federal Civilian Service, awarded to her by John F. Kennedy in 1962.

<span class="mw-page-title-main">Hormonal intrauterine device</span> Intrauterine device

A hormonal intrauterine device (IUD), also known as an intrauterine system (IUS) with progestogen and sold under the brand name Mirena among others, is an intrauterine device that releases a progestogenic hormonal agent such as levonorgestrel into the uterus. It is used for birth control, heavy menstrual periods, and to prevent excessive build of the lining of the uterus in those on estrogen replacement therapy. It is one of the most effective forms of birth control with a one-year failure rate around 0.2%. The device is placed in the uterus and lasts three to eight years. Fertility often returns quickly following removal.

<span class="mw-page-title-main">David A. Kessler</span> American pediatrician & attorney (born 1951)

David Aaron Kessler is an American pediatrician, attorney, author, and administrator serving as Chief Science Officer of the White House COVID-19 Response Team since 2021. Kessler was the commissioner of the Food and Drug Administration (FDA) from November 8, 1990, to February 28, 1997. He co-chaired the Biden-Harris transition’s COVID-19 Advisory Board from November 2020 to January 2021 and was the head of Operation Warp Speed, the U.S. government program to accelerate the development of COVID-19 vaccines and other treatments, from January to February 2021.

<span class="mw-page-title-main">Population Council</span>

The Population Council is an international, nonprofit, non-governmental organization. The Council conducts research in biomedicine, social science, and public health and helps build research capacities in developing countries. One-third of its research relates to HIV and AIDS; while its other major program areas are still linked to its early foundation in reproductive health and its relation to poverty, youth, and gender. For example, the Population Council strives to teach boys that they can be involved in contraceptive methods regardless of stereotypes that limit male responsibility in child bearing. The organization held the license for Norplant contraceptive implant, and now holds the license for Mirena intrauterine system. The Population Council also publishes the journal Population and Development Review, which reports scientific research on the interrelationships between population and socioeconomic development. It also provides a forum for discussion on related issues of public policy and Studies in Family Planning, which focuses on public health, social science, and biomedical research involving sexual and reproductive health, fertility, and family planning.

<span class="mw-page-title-main">Hormonal contraception</span> Birth control methods that act on the endocrine system

Hormonal contraception refers to birth control methods that act on the endocrine system. Almost all methods are composed of steroid hormones, although in India one selective estrogen receptor modulator is marketed as a contraceptive. The original hormonal method—the combined oral contraceptive pill—was first marketed as a contraceptive in 1960. In the ensuing decades, many other delivery methods have been developed, although the oral and injectable methods are by far the most popular. Hormonal contraception is highly effective: when taken on the prescribed schedule, users of steroid hormone methods experience pregnancy rates of less than 1% per year. Perfect-use pregnancy rates for most hormonal contraceptives are usually around the 0.3% rate or less. Currently available methods can only be used by women; the development of a male hormonal contraceptive is an active research area.

<span class="mw-page-title-main">Etonogestrel</span> Chemical compound

Etonogestrel is a medication which is used as a means of birth control for women. It is available as an implant placed under the skin of the upper arm under the brand names Nexplanon and Implanon. It is a progestin that is also used in combination with ethinylestradiol, an estrogen, as a vaginal ring under the brand names NuvaRing and Circlet. Etonogestrel is effective as a means of birth control and lasts at least three or four years with some data showing effectiveness for five years. Following removal, fertility quickly returns.

<span class="mw-page-title-main">Diana Zuckerman</span> American health policy analyst

Diana M. Zuckerman is an American health policy analyst who focuses on the implications of policies for public health and patients' health. She specializes in national health policy, particularly in women's health and the safety and effectiveness of medical products. She is the President of the National Center for Health Research and the Cancer Prevention and Treatment Fund.

The National Women's Health Network (NWHN) is a non-profit women's health advocacy organization located in Washington, D.C. It was founded in 1975 by Barbara Seaman, Alice Wolfson, Belita Cowan, Mary Howell, and Phyllis Chesler. The stated mission of the organization is to give women a greater voice within the healthcare system. The NWHN researches and lobbies federal agencies on such issues as AIDS, reproductive rights, breast cancer, older women's health, and new contraceptive technologies. The Women's Health Voice, the NWHN's health information program, provides independent research on a variety of women's health topics.

Sybil Niden Goldrich is a women’s health advocate, primarily concerning breast implants.

<span class="mw-page-title-main">Contraceptive implant</span> Implantable medical device used for birth control

A contraceptive implant is an implantable medical device used for the purpose of birth control. The implant may depend on the timed release of hormones to hinder ovulation or sperm development, the ability of copper to act as a natural spermicide within the uterus, or it may work using a non-hormonal, physical blocking mechanism. As with other contraceptives, a contraceptive implant is designed to prevent pregnancy, but it does not protect against sexually transmitted infections.

<span class="mw-page-title-main">Medroxyprogesterone acetate</span> Injectable form of birth control

Medroxyprogesterone acetate (MPA), also known as depot medroxyprogesterone acetate (DMPA) in injectable form and sold under the brand name Depo-Provera among others, is a hormonal medication of the progestin type. It is used as a method of birth control and as a part of menopausal hormone therapy. It is also used to treat endometriosis, abnormal uterine bleeding, paraphilia, and certain types of cancer. The medication is available both alone and in combination with an estrogen. It is taken by mouth, used under the tongue, or by injection into a muscle or fat.

Sheldon Jerome Segal was an American embryologist and biochemist who spent his entire career working on contraception, and made major innovations in the field of long-lasting alternatives, with Chilean physician Horacio Croxatto, including in the creation of Norplant, the first major development advance in birth control since the birth control pill.

<span class="mw-page-title-main">Birth control movement in the United States</span> Social reform campaign beginning in 1914

The birth control movement in the United States was a social reform campaign beginning in 1914 that aimed to increase the availability of contraception in the U.S. through education and legalization. The movement began in 1914 when a group of political radicals in New York City, led by Emma Goldman, Mary Dennett, and Margaret Sanger, became concerned about the hardships that childbirth and self-induced abortions brought to low-income women. Since contraception was considered to be obscene at the time, the activists targeted the Comstock laws, which prohibited distribution of any "obscene, lewd, and/or lascivious" materials through the mail. Hoping to provoke a favorable legal decision, Sanger deliberately broke the law by distributing The Woman Rebel, a newsletter containing a discussion of contraception. In 1916, Sanger opened the first birth control clinic in the United States, but the clinic was immediately shut down by police, and Sanger was sentenced to 30 days in jail.

<span class="mw-page-title-main">Birth control in the United States</span>

Birth control in the United States is available in many forms. Some of the forms available at drugstores and some retail stores are male condoms, female condoms, sponges, spermicides, over-the-counter progestin-only contraceptive pills, and over-the-counter emergency contraception. Forms available at pharmacies with a doctor's prescription or at doctor's offices are oral contraceptive pills, patches, vaginal rings, diaphragms, shots/injections, cervical caps, implantable rods, and intrauterine devices (IUDs). Sterilization procedures, including tubal ligations and vasectomies, are also performed.

A contraceptive mandate is a government regulation or law that requires health insurers, or employers that provide their employees with health insurance, to cover some contraceptive costs in their health insurance plans.

In the 1960s and 1970s, the Indian Health Service (IHS) and collaborating physicians sustained a practice of performing sterilizations on Native American women, in many cases without the free and informed consent of their patients. In some cases, women were misled into believing that the sterilization procedure was reversible. In other cases, sterilization was performed without the adequate understanding and consent of the patient, including cases in which the procedure was performed on minors as young as 11 years old. A compounding factor was the tendency of doctors to recommend sterilization to poor and minority women in cases where they would not have done so to a wealthier white patient. Other cases of abuse have been documented as well, including when health providers did not tell women they were going to be sterilized, or other forms of coercion including threatening to take away their welfare or healthcare.

References

  1. 1 2 Lichtenstein, Grace (Winter 2011). "Sybil Schwartz Shainwald '45, Women's Advocate" (PDF). James Madison High School Alumni News. 17 (1): 4. Retrieved 2 May 2016.
  2. ↑ Tonti, Marcus (Spring 2010). "Attorney Sybil Shainwald '72GSAS launches fellowship for oral history". Columbia Magazine. Retrieved 2 May 2016.
  3. 1 2 3 4 oasis.lib.harvard.edu/oasis/deliver/~sch01445. "Shainwald, Sybil. Papers of Sybil Shainwald, 1924-2012 (inclusive), 1978-2012 (bulk)". Radcliffe Institute for Advanced Study, Harvard University. Retrieved 2 May 2016.{{cite web}}: CS1 maint: numeric names: authors list (link)
  4. 1 2 3 Shainwald, Sybil (2008). "DES Litigation". In Seaman, Barbara; Eldridge, Laura (eds.). Voices of the Women's Health Movement. Seven Stories Press. ISBN   978-1609804442.
  5. 1 2 Duncan, Laura (Nov 1995). "Norplant: The Next Mass Tort". ABA Journal. 81.
  6. 1 2 Shainwald, Sybil. "Women's Health Advocate". Sybil Shainwald – Attorney for Women's Reproductive Rights. Retrieved 4 May 2016.
  7. ↑ "In Recognition of Women's History Month: Edith I. Spivack Award Reception Set for March 24" (PDF). New York County Lawyer. 6 (1): 10. Jan–Feb 2010. Retrieved 4 May 2016.
  8. ↑ Chesler, Phyllis (14 November 2008). "To Stop Women's Silent Suffering". Salon. Retrieved 16 May 2016.
  9. ↑ Fraser, Laura (Nov–Dec 1985). "Dumping Depo at Home". Mother Jones.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.